| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.45B | -20.2% |
| Cost of Revenue | $2.94B | -19.0% |
| Gross Profit | $514.9M | -26.2% |
| R&D Expense | $12.4M | -35.8% |
| SG&A Expense | $206.6M | -6.6% |
| Operating Income | -$21.5M | -200.9% |
| Interest Expense | $69.9M | -13.9% |
| Pre-tax Income | -$7.8M | +75.2% |
| Income Tax | $8.3M | +288.6% |
| Net Income | -$146.3M | -1070.4% |
| EPS (Basic) | -$2.61 | -1086.4% |
| EPS (Diluted) | -$2.61 | -1086.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.0M | -86.1% |
| Accounts Receivable | $347.1M | -2.9% |
| Inventory | $589.5M | -13.0% |
| Current Assets | $814.5M | -35.1% |
| Total Assets | $4.25B | -18.3% |
| Current Liabilities | $827.8M | -23.1% |
| Long-term Debt | $1.41B | -26.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$150.7M | -146.4% |
| Capital Expenditures | $87.1M | -13.4% |
| Investing Cash Flow | $412.0M | +2552.4% |
| Financing Cash Flow | -$522.7M | -44.3% |
| Free Cash Flow | -$237.8M | -206.0% |
| Total Liabilities |
| $2.57B |
| -23.6% |
| Stockholders' Equity | $1.69B | -8.6% |